Serum AFU, 5’-NT and AFP as biomarkers for primary hepatocellular carcinoma diagnosis
To evaluate the clinical value of serum α-L-fucosidase (AFU), 5’-nucleotidase (5’-NT) and alpha fetoprotein (AFP) as biomarkers for primary hepatocellular carcinoma (PHC) diagnosis. Methods: Thirty six primary hepatocellular carcinoma (PHC) patients and 36 healthy controls were recruited in this stu...
Main Authors: | Junna Zhu, Gongde Chen, Jinying Xu, Xiu Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2017-10-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2017-0051 |
Similar Items
-
Evaluation of alpha-l-fucosidase for the diagnosis of hepatocellular carcinoma based on meta-analysis
by: Xi Lei, et al.
Published: (2020-09-01) -
Evaluation of the diagnostic value of alpha‐l‐fucosidase, alpha‐fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma
by: Shi-Yan Zhang, et al.
Published: (2015-01-01) -
Identification of Plasma hsa_circ_0005397 and Combined With Serum AFP, AFP-L3 as Potential Biomarkers for Hepatocellular Carcinoma
by: Ruoyu Liu, et al.
Published: (2021-02-01) -
Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter Analysis
by: Siyu Liu, et al.
Published: (2022-08-01) -
Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
by: Tianying Ren, et al.
Published: (2023-11-01)